Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its third-quarter 2024 earnings, highlighting a steady increase in revenue and strategic developments in product innovation and market expansion. Despite ...
Typically, the earnings call immediately follows the release of the quarterly earnings report. While the SEC requires companies to report earnings and file a 10-Q (quarterly) or 10-K (annual ...